Position in GSK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,969,943
-$122,309 QoQ
Shares Held
37,580
-0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#269
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nicholas Hoffman & Company, LLC. holds $35,503,201 across 12 Drug Manufacturers - General names. GSK ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,776 | $11,725,628 | |
| 2 | JNJ |
Johnson & Johnson
|
34,137 | $8,669,773 | |
| 3 | ABBV |
AbbVie Inc.
|
10,274 | $2,585,349 | |
| 4 | AZN |
Astrazeneca PLC
|
11,897 | $2,255,909 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
35,055 | $2,019,869 | |
| 6 | GSK |
GSK plc
This page
|
37,580 | $1,969,943 | |
| 7 | MRK |
Merck & Co., Inc.
|
15,146 | $1,946,261 | |
| 8 | NVS |
Novartis AG
|
9,771 | $1,531,311 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,969,943 | 37,580 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,092,252 | 37,910 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,204,348 | 44,950 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,054,329 | 47,598 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,829,107 | 47,633 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,852,779 | 47,826 | Shares | Sole | 2025-06-23 | |
| 2024-12-31 | $1,595,492 | 47,176 | Shares | Sole | 2025-06-23 | |
| 2024-09-30 | $1,653,800 | 40,455 | Shares | Sole | 2025-06-23 | |
| 2024-06-30 | $1,597,249 | 41,487 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,778,847 | 41,494 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,558,632 | 42,057 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,565,855 | 43,196 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,554,688 | 43,622 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,569,078 | 44,100 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,507,962 | 42,913 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,297,598 | 44,091 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,080,959 | 48,741 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,056,630 | 48,138 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,084,505 | 48,193 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,846,610 | 49,274 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,942,110 | 49,727 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,720,588 | 49,153 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,321,597 | 36,616 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,080,754 | 29,275 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,193,083 | 29,822 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,200,683 | 32,309 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||